Madrigal Pharmaceuticals Inc (MDGL)
Net Income
$55.44M
Quarterly · Period ending: · USD
MDGL Net Income
Latest reported$55.44Mperiod ending
Latest reported$55.44Mperiod ending
MDGL Quarterly Net Income (-$8.76M → $55.44M)
Quarterly net income
High-resolution chart · PNG
MDGL net income history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income (USD) |
|---|---|
| 55,442,000 | |
| -57,939,000 | |
| -94,391,000 | |
| -58,575,000 | |
| -114,190,000 | |
| -42,281,000 | |
| -73,238,000 | |
| -59,416,000 | |
| -106,964,000 | |
| -151,971,000 | |
| -147,541,000 | |
| -112,194,000 | |
| -98,740,000 | |
| -85,800,000 | |
| -76,896,000 | |
| -85,905,000 | |
| -81,197,000 | |
| -70,730,000 | |
| -57,518,000 | |
| -64,549,000 | |
| -63,100,000 | |
| -61,651,000 | |
| -52,546,000 | |
| -59,123,000 | |
| -57,963,000 | |
| -49,023,000 | |
| -36,135,000 | |
| -27,740,000 | |
| -21,429,000 | |
| -19,699,000 | |
| -15,080,000 | |
| -11,475,000 | |
| -8,512,000 | |
| -6,460,000 | |
| -6,364,000 | |
| -8,445,000 | |
| -8,363,000 | |
| -8,346,999 | |
| -5,999,000 | |
| -7,749,269 | |
| -14,048,740 | |
| -2,877,000 | |
| -6,524,000 | |
| -10,536,000 | |
| -17,628,000 | |
| -19,800,000 | |
| -20,707,000 | |
| -20,352,000 | |
| -19,966,000 | |
| -22,286,000 | |
| -23,557,000 | |
| -24,162,000 | |
| -22,515,000 | |
| -22,787,000 | |
| -20,728,000 | |
| -18,123,000 | |
| -14,996,000 | |
| -14,620,000 | |
| -15,051,000 | |
| -10,743,000 | |
| -12,734,000 | |
| -12,502,000 | |
| -11,401,000 | |
| -8,823,000 | |
| -10,262,000 | |
| -9,074,000 | |
| -9,308,000 | |
| -7,037,000 | |
| 118,119,000 | |
| -8,495,000 | |
| -23,499,000 | |
| -25,953,000 | |
| -26,321,000 | |
| -22,694,000 | |
| -17,650,000 | |
| -15,524,000 | |
| -14,875,000 | |
| -16,741,000 | |
| -16,355,000 | |
| -12,487,000 | |
| -13,927,000 | |
| -14,928,000 | |
| -14,928,000 | |
| -15,492,000 | |
| -26,686,000 | |
| -26,686,000 | |
| -17,857,000 | |
| -8,757,000 |